Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
27
OMID Quote, Financials, Valuation and Earnings
Last price:
$0.0300
Seasonality move
:
34.39%
Day range:
$0.0250 - $0.0250
52-week range:
$0.0023 - $0.0420
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.11x
P/B ratio:
6.24x
Volume:
9.5K
Avg. volume:
24.1K
1-year change:
15.42%
Market cap:
$1.7M
Revenue:
$394.1K
EPS (TTM):
-$0.00
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OMID
OMID Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$283.1M | $0.07 | 16.03% | -30.17% | $31.85 |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$1.1B | $1.53 | 88.89% | -58.59% | $449.32 |
|
ATHXQ
Athersys, Inc.
|
-- | -- | -- | -- | -- |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
$754.8M | $1.00 | 3.04% | 4.71% | $88.87 |
|
SVRA
Savara, Inc.
|
-- | -$0.14 | -- | -12.28% | $10.81 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OMID
OMID Holdings, Inc.
|
$0.0250 | -- | $1.7M | -- | $0.00 | 0% | 6.11x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$22.20 | $31.85 | $3.8B | 9.65x | $0.00 | 0% | 3.49x |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$318.85 | $449.32 | $41B | 141.27x | $0.00 | 0% | 11.46x |
|
ATHXQ
Athersys, Inc.
|
$0.0001 | -- | $6.2K | -- | $0.00 | 0% | 0.02x |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
$55.50 | $88.87 | $10.3B | 31.15x | $0.00 | 0% | 3.33x |
|
SVRA
Savara, Inc.
|
$5.56 | $10.81 | $1.1B | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OMID
OMID Holdings, Inc.
|
80.22% | 0.694 | -- | 21.30x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
4.08% | 2.895 | 1.15% | 3.40x |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
79% | 1.662 | 5.64% | 2.51x |
|
ATHXQ
Athersys, Inc.
|
-- | 467.538 | -- | -- |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
9.55% | -0.343 | 5.63% | 3.25x |
|
SVRA
Savara, Inc.
|
12.84% | -1.345 | 2.43% | 11.56x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OMID
OMID Holdings, Inc.
|
$39.6K | -$44.4K | -28.6% | -60.74% | -47.69% | $26.8K |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$257.8M | $17.4M | 41.28% | 43.78% | 6.12% | -$52.7M |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$829.3M | $131.7M | 10.18% | 107.73% | 12.01% | $140.3M |
|
ATHXQ
Athersys, Inc.
|
-- | -- | -- | -- | -- | -- |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
$614.5M | $99.8M | 5.33% | 5.89% | 11.16% | $56.6M |
|
SVRA
Savara, Inc.
|
-$40K | -$33.4M | -67.27% | -80.59% | -- | -$25.1M |
OMID Holdings, Inc. vs. Competitors
-
Which has Higher Returns OMID or ACAD?
ACADIA Pharmaceuticals, Inc. has a net margin of 40.6% compared to OMID Holdings, Inc.'s net margin of 96.33%. OMID Holdings, Inc.'s return on equity of -60.74% beat ACADIA Pharmaceuticals, Inc.'s return on equity of 43.78%.
Company Gross Margin Earnings Per Share Invested Capital OMIDOMID Holdings, Inc.42.54% $0.00 $404.5K ACADACADIA Pharmaceuticals, Inc.90.77% $1.60 $1.3B -
What do Analysts Say About OMID or ACAD?
OMID Holdings, Inc. has a consensus price target of --, signalling upside risk potential of 560%. On the other hand ACADIA Pharmaceuticals, Inc. has an analysts' consensus of $31.85 which suggests that it could grow by 43.47%. Given that OMID Holdings, Inc. has higher upside potential than ACADIA Pharmaceuticals, Inc., analysts believe OMID Holdings, Inc. is more attractive than ACADIA Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OMIDOMID Holdings, Inc.0 0 0 ACADACADIA Pharmaceuticals, Inc.12 4 1 -
Is OMID or ACAD More Risky?
OMID Holdings, Inc. has a beta of 0.875, which suggesting that the stock is 12.476% less volatile than S&P 500. In comparison ACADIA Pharmaceuticals, Inc. has a beta of 0.833, suggesting its less volatile than the S&P 500 by 16.67%.
-
Which is a Better Dividend Stock OMID or ACAD?
OMID Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ACADIA Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OMID Holdings, Inc. pays -- of its earnings as a dividend. ACADIA Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OMID or ACAD?
OMID Holdings, Inc. quarterly revenues are $93.1K, which are smaller than ACADIA Pharmaceuticals, Inc. quarterly revenues of $284M. OMID Holdings, Inc.'s net income of $37.8K is lower than ACADIA Pharmaceuticals, Inc.'s net income of $273.6M. Notably, OMID Holdings, Inc.'s price-to-earnings ratio is -- while ACADIA Pharmaceuticals, Inc.'s PE ratio is 9.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OMID Holdings, Inc. is 6.11x versus 3.49x for ACADIA Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OMIDOMID Holdings, Inc.6.11x -- $93.1K $37.8K ACADACADIA Pharmaceuticals, Inc.3.49x 9.65x $284M $273.6M
-
Which has Higher Returns OMID or ALNY?
Alnylam Pharmaceuticals, Inc. has a net margin of 40.6% compared to OMID Holdings, Inc.'s net margin of 16.99%. OMID Holdings, Inc.'s return on equity of -60.74% beat Alnylam Pharmaceuticals, Inc.'s return on equity of 107.73%.
Company Gross Margin Earnings Per Share Invested Capital OMIDOMID Holdings, Inc.42.54% $0.00 $404.5K ALNYAlnylam Pharmaceuticals, Inc.75.6% $1.37 $3.8B -
What do Analysts Say About OMID or ALNY?
OMID Holdings, Inc. has a consensus price target of --, signalling upside risk potential of 560%. On the other hand Alnylam Pharmaceuticals, Inc. has an analysts' consensus of $449.32 which suggests that it could grow by 40.92%. Given that OMID Holdings, Inc. has higher upside potential than Alnylam Pharmaceuticals, Inc., analysts believe OMID Holdings, Inc. is more attractive than Alnylam Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OMIDOMID Holdings, Inc.0 0 0 ALNYAlnylam Pharmaceuticals, Inc.14 8 0 -
Is OMID or ALNY More Risky?
OMID Holdings, Inc. has a beta of 0.875, which suggesting that the stock is 12.476% less volatile than S&P 500. In comparison Alnylam Pharmaceuticals, Inc. has a beta of 0.387, suggesting its less volatile than the S&P 500 by 61.27%.
-
Which is a Better Dividend Stock OMID or ALNY?
OMID Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alnylam Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OMID Holdings, Inc. pays -- of its earnings as a dividend. Alnylam Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OMID or ALNY?
OMID Holdings, Inc. quarterly revenues are $93.1K, which are smaller than Alnylam Pharmaceuticals, Inc. quarterly revenues of $1.1B. OMID Holdings, Inc.'s net income of $37.8K is lower than Alnylam Pharmaceuticals, Inc.'s net income of $186.4M. Notably, OMID Holdings, Inc.'s price-to-earnings ratio is -- while Alnylam Pharmaceuticals, Inc.'s PE ratio is 141.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OMID Holdings, Inc. is 6.11x versus 11.46x for Alnylam Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OMIDOMID Holdings, Inc.6.11x -- $93.1K $37.8K ALNYAlnylam Pharmaceuticals, Inc.11.46x 141.27x $1.1B $186.4M
-
Which has Higher Returns OMID or ATHXQ?
Athersys, Inc. has a net margin of 40.6% compared to OMID Holdings, Inc.'s net margin of --. OMID Holdings, Inc.'s return on equity of -60.74% beat Athersys, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital OMIDOMID Holdings, Inc.42.54% $0.00 $404.5K ATHXQAthersys, Inc.-- -- -- -
What do Analysts Say About OMID or ATHXQ?
OMID Holdings, Inc. has a consensus price target of --, signalling upside risk potential of 560%. On the other hand Athersys, Inc. has an analysts' consensus of -- which suggests that it could grow by 5499900%. Given that Athersys, Inc. has higher upside potential than OMID Holdings, Inc., analysts believe Athersys, Inc. is more attractive than OMID Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OMIDOMID Holdings, Inc.0 0 0 ATHXQAthersys, Inc.0 0 0 -
Is OMID or ATHXQ More Risky?
OMID Holdings, Inc. has a beta of 0.875, which suggesting that the stock is 12.476% less volatile than S&P 500. In comparison Athersys, Inc. has a beta of 55.578, suggesting its more volatile than the S&P 500 by 5457.768%.
-
Which is a Better Dividend Stock OMID or ATHXQ?
OMID Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Athersys, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OMID Holdings, Inc. pays -- of its earnings as a dividend. Athersys, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OMID or ATHXQ?
OMID Holdings, Inc. quarterly revenues are $93.1K, which are larger than Athersys, Inc. quarterly revenues of --. OMID Holdings, Inc.'s net income of $37.8K is higher than Athersys, Inc.'s net income of --. Notably, OMID Holdings, Inc.'s price-to-earnings ratio is -- while Athersys, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OMID Holdings, Inc. is 6.11x versus 0.02x for Athersys, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OMIDOMID Holdings, Inc.6.11x -- $93.1K $37.8K ATHXQAthersys, Inc.0.02x -- -- --
-
Which has Higher Returns OMID or BMRN?
BioMarin Pharmaceutical, Inc. has a net margin of 40.6% compared to OMID Holdings, Inc.'s net margin of -5.2%. OMID Holdings, Inc.'s return on equity of -60.74% beat BioMarin Pharmaceutical, Inc.'s return on equity of 5.89%.
Company Gross Margin Earnings Per Share Invested Capital OMIDOMID Holdings, Inc.42.54% $0.00 $404.5K BMRNBioMarin Pharmaceutical, Inc.68.65% -$0.24 $6.7B -
What do Analysts Say About OMID or BMRN?
OMID Holdings, Inc. has a consensus price target of --, signalling upside risk potential of 560%. On the other hand BioMarin Pharmaceutical, Inc. has an analysts' consensus of $88.87 which suggests that it could grow by 60.13%. Given that OMID Holdings, Inc. has higher upside potential than BioMarin Pharmaceutical, Inc., analysts believe OMID Holdings, Inc. is more attractive than BioMarin Pharmaceutical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OMIDOMID Holdings, Inc.0 0 0 BMRNBioMarin Pharmaceutical, Inc.14 5 0 -
Is OMID or BMRN More Risky?
OMID Holdings, Inc. has a beta of 0.875, which suggesting that the stock is 12.476% less volatile than S&P 500. In comparison BioMarin Pharmaceutical, Inc. has a beta of 0.293, suggesting its less volatile than the S&P 500 by 70.697%.
-
Which is a Better Dividend Stock OMID or BMRN?
OMID Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BioMarin Pharmaceutical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OMID Holdings, Inc. pays -- of its earnings as a dividend. BioMarin Pharmaceutical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OMID or BMRN?
OMID Holdings, Inc. quarterly revenues are $93.1K, which are smaller than BioMarin Pharmaceutical, Inc. quarterly revenues of $895M. OMID Holdings, Inc.'s net income of $37.8K is higher than BioMarin Pharmaceutical, Inc.'s net income of -$46.6M. Notably, OMID Holdings, Inc.'s price-to-earnings ratio is -- while BioMarin Pharmaceutical, Inc.'s PE ratio is 31.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OMID Holdings, Inc. is 6.11x versus 3.33x for BioMarin Pharmaceutical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OMIDOMID Holdings, Inc.6.11x -- $93.1K $37.8K BMRNBioMarin Pharmaceutical, Inc.3.33x 31.15x $895M -$46.6M
-
Which has Higher Returns OMID or SVRA?
Savara, Inc. has a net margin of 40.6% compared to OMID Holdings, Inc.'s net margin of --. OMID Holdings, Inc.'s return on equity of -60.74% beat Savara, Inc.'s return on equity of -80.59%.
Company Gross Margin Earnings Per Share Invested Capital OMIDOMID Holdings, Inc.42.54% $0.00 $404.5K SVRASavara, Inc.-- -$0.13 $233M -
What do Analysts Say About OMID or SVRA?
OMID Holdings, Inc. has a consensus price target of --, signalling upside risk potential of 560%. On the other hand Savara, Inc. has an analysts' consensus of $10.81 which suggests that it could grow by 94.47%. Given that OMID Holdings, Inc. has higher upside potential than Savara, Inc., analysts believe OMID Holdings, Inc. is more attractive than Savara, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OMIDOMID Holdings, Inc.0 0 0 SVRASavara, Inc.6 0 0 -
Is OMID or SVRA More Risky?
OMID Holdings, Inc. has a beta of 0.875, which suggesting that the stock is 12.476% less volatile than S&P 500. In comparison Savara, Inc. has a beta of 0.316, suggesting its less volatile than the S&P 500 by 68.412%.
-
Which is a Better Dividend Stock OMID or SVRA?
OMID Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Savara, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OMID Holdings, Inc. pays -- of its earnings as a dividend. Savara, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OMID or SVRA?
OMID Holdings, Inc. quarterly revenues are $93.1K, which are larger than Savara, Inc. quarterly revenues of --. OMID Holdings, Inc.'s net income of $37.8K is higher than Savara, Inc.'s net income of -$32.2M. Notably, OMID Holdings, Inc.'s price-to-earnings ratio is -- while Savara, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OMID Holdings, Inc. is 6.11x versus -- for Savara, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OMIDOMID Holdings, Inc.6.11x -- $93.1K $37.8K SVRASavara, Inc.-- -- -- -$32.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 4
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 4
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 4
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
